Peter H. O'Donnell to Clinical Trials as Topic
This is a "connection" page, showing publications Peter H. O'Donnell has written about Clinical Trials as Topic.
Connection Strength
0.173
-
Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma. BJU Int. 2016 Nov; 118(5):681-691.
Score: 0.097
-
Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: a report from the Bladder Cancer Advocacy Network Clinical Trials Working Group. Cancer. 2013 Jun 01; 119(11):1994-8.
Score: 0.077